Filters

Lurasidone manufacturers

Filters

lurasidone

Tablets, film coated 18.5 mg, 37 mg, 74 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Vietnam
Manufacturer #437

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 39 days

lurasidone

Tablets, film coated 18.5 mg, 37.5 mg, 74 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #11864
A pharmaceutical manufacturer based in the EU that is active in 20+ countries worldwide selling its products in EU, CIS, LATAM, and South-East Asia for 30+ years. Key production lines are Rx medicines, OTC drugs, and dietary supplements with EU GMP certification. The company's main therapeutic areas include oncology, cardiology, psychiatry, and internal medicine. The company provides eCTD format dossiers as well as BE studies and stability studies.

Manufacturer usually replies in 21 days

lurasidone

Tablets 20 mg, 40 mg, 60 mg, 80 mg, 120 mg

Dossier type
US CTD
Dossier status
Under development
Country of origin
United States
GMP approvals
FDA
Manufacturer #38860
US-based pharmaceutical company developing and commercializing Rx and OTC generic and specialty medicines for domestic and international markets. Portfolio covers multiple therapeutic areas and dosage forms in line with US FDA regulatory standards. Committed to quality manufacturing and reliable pharmaceutical supply.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Lurasidone is an antipsychotic medication used to treat schizophrenia and bipolar disorder. Suppliers of lurasidone market it in the form of oral tablets. Alternatives to it are other antipsychotic medications such as perospirone, risperidone, paliperidone, and iloperidone. The developer and earliest manufacturer of lurasidone medications was Sunovion Pharmaceuticals, which first introduced the drug into the market in 2010 under the trade name Latuda. It has since become approved in Canada and across the EU and has seen widespread use, with over 2 million prescriptions for it being registered annually in the U.S. alone. Lurasidone suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified lurasidone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.